Bruker shares jumped 15% after the company delivered better-than-expected bookings growth in key AI-driven segments and reaffirmed its full-year outlook despite ongoing organic revenue challenges and margin pressure.
- Q1 2026 revenue was $823 million, up 2.7% year-over-year, driven by an FX tailwind (4.5%) and acquisitions (2.6%), offsetting a 4.4% organic revenue decline.
- The Bruker Scientific Instruments (BSI) segment showed 5% organic revenue decline but offset by high single-digit organic bookings growth, led by AI-driven semiconductor metrology and scientific software/digitization businesses each growing bookings over 20%.
- BEST segment reported 3% organic revenue growth and secured approximately $680 million in multi-year orders across research instruments and superconductors.
- Non-GAAP gross margin declined to 50% and operating margin to 10.2%, pressured by currency headwinds, although both were still better than expectations.
- Non-GAAP EPS of $0.31 declined versus prior year’s $0.47 but beat prior expectations; management expects momentum to return to organic revenue growth in Q2 and beyond.
Community Discussion